COMMUNIQUÉS West-GlobeNewswire

Wildflower Featured in NetworkNewsWire Publication Discussing Sweeping Growth of Cannabis Industry
29/04/2019
NEW YORK, April 29, 2019 (GLOBE NEWSWIRE) -- via NetworkWire — Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted [...]
Cassava Sciences Reports First Quarter 2019 Financial Results
29/04/2019
2019 Focus is on Fiscal Discipline and Advancing Development Pipeline AUSTIN, Texas, April 29, 2019 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a biopharmaceutical company, today reported financial [...]
International Stem Cell Corporation Completes Enrollment and Dosing in its Parkinson's Disease Clinical Trial
29/04/2019
CARLSBAD, Calif., April 29, 2019 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQX: ISCO) ( www.internationalstemcell.com ) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company [...]
Arbutus to Report First Quarter 2019 Financial Results
29/04/2019
WARMINSTER, Pa., April 29, 2019 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that it has scheduled its [...]
Minerva Neurosciences to Report First Quarter 2019 Financial Results and Business Updates on May 6, 2019
29/04/2019
Management to host conference call WALTHAM, Mass., April 29, 2019 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to [...]
ContraVir Pharmaceuticals to Present at the 2019 ThinkEquity Conference
29/04/2019
EDISON, N.J., April 29, 2019 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from [...]
ChemoCentryx to Hold First Quarter 2019 Financial Results Conference Call on Monday, May 6, 2019
29/04/2019
MOUNTAIN VIEW, Calif., April 29, 2019 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company's first quarter 2019 financial results will be released after market close on Monday, May 6 [...]
Centrexion Therapeutics Announces CNTX-4975 Data Presentations at the 2019 British Society for Rheumatology Annual Conference and Osteoarthritis Research Society International 2019 World Congress
29/04/2019
BOSTON, April 29, 2019 (GLOBE NEWSWIRE) -- Centrexion Therapeutics Corporation , a company focused on developing non-opioid, non-addictive therapeutics for the treatment of chronic pain, today announced it will present [...]
Catalyst Biosciences & Mosaic Biosciences Present Preclinical Data on Pegylated CB 2782 for the Treatment of Dry Age-Related Macular Degeneration
29/04/2019
A single intravitreal injection of 125 μg CB 2782-PEG achieved complete, rapid and sustained pharmacodynamic inhibition (>99%) of complement factor 3 (C3) in non-human primates (NHP), supporting dosing three to four [...]
U.S. FDA accepts New Drug Application for review and grants Priority Review for darolutamide
29/04/2019
Orion Corporation Press release 29 April 2019 at 3.00 p.m. EEST U.S. FDA accepts New Drug Application for review and grants Priority Review for darolutamide Orion Corporation and Bayer today announced that the U.S. Food [...]
EDAP TMS SA : EDAP to Showcase Suite of Therapeutic Ultrasound Products During the American Urology Association Annual Meeting
29/04/2019
EDAP to Provide Live Demonstrations and Host Q&A with Interested Parties at Booth #2211 LYON, France, April 29, 2019 -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it [...]
MediPharm Labs Appoints Former Johnson & Johnson Group Product Director as Chief Strategy Officer
29/04/2019
New Pharma Executive Position Created to Advance Corporate Strategy, Global Growth and Strategic Partnerships TORONTO, April 29, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“ [...]
Hendrick Health System selects Allscripts to provide single patient record, billing and database solution
29/04/2019
Health system signs strategic agreement to deploy suite of solutions including Allscripts Sunrise™ Ambulatory EHR, Sunrise™ Financial Manager, Sunrise™ Health Information Manager, FollowMyHealth® and Allscripts Patient [...]
Foamix to Present Late Breaking Data at the 77th Annual Meeting of the Society for Investigative Dermatology
29/04/2019
REHOVOT, Israel and BRIDGEWATER, N.J., April 29, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (“Foamix” or the “Company”), a clinical stage specialty pharmaceutical company focused on developing [...]
Teneobio Announces US FDA Approval of the Investigational New Drug Application for TNB-383B and the Initiation of Phase I Clinical Studies in Multiple Myeloma Patients
29/04/2019
NEWARK, Calif., April 29, 2019 (GLOBE NEWSWIRE) -- Teneobio, Inc. and its affiliate TeneoOne, Inc. announced today that their investigational new drug application (IND) for TNB-383B, a bispecific T-cell engaging [...]
Krystal Biotech Announces Five Presentations of Clinical and Preclinical Data at the Society for Investigative Dermatology Annual Meeting
29/04/2019
PITTSBURGH, April 29, 2019 (GLOBE NEWSWIRE) -- Krystal Biotech Inc. , (“Krystal”) (NASDAQ: KRYS), a gene therapy company developing medicines to treat rare skin diseases announces presentations of clinical data for [...]
Avadel Pharmaceuticals Announces Appointment of Jordan Dubow, M.D., as Chief Medical Officer
29/04/2019
DUBLIN, Ireland, April 29, 2019 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218 for sleep disorders, today announced that it has appointed Jordan Dubow, M.D., as [...]
Evolus to Participate in Two Upcoming Investor Conferences
29/04/2019
IRVINE, Calif., April 29, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ:EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, announced today that members of [...]
PetMed Express D/B/A 1-800-PetMeds to Announce Its Fiscal Year End Financial Results on May 6, 2019
29/04/2019
DELRAY BEACH, Fla., April 29, 2019 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS) will announce its financial results for the fiscal year ended March 31, 2019 on Monday, May 6, 2019 at 8:00 A.M. Eastern Time, [...]

Pages